Introduction {#s1}
============

Circadian rhythms allow organisms to orchestrate behavioral and physiological outputs in anticipation of predictable diurnal changes in the environment. These rhythms are generated by endogenous molecular clocks that entrain to environmental cycles, predominantly light and temperature, and can maintain rhythms when released into constant conditions (free-run). A conserved mechanistic feature of circadian clocks is an auto-regulatory transcriptional feedback loop in which circadian proteins rhythmically regulate their own expression to generate a clock, and also drive a global program of cycling gene expression. Discovery of this clock mechanism was revolutionary and has received well-deserved recognition, but critical aspects of how the clock is sustained remain unclear.

PERIOD (PER) and TIMELESS (TIM) are the auto-regulating elements of the circadian clock in Drosophila ([@bib2]; [@bib29]; [@bib76]). The expression of *per* and *tim* is driven by circadian transcription factors CLOCK (CLK) and CYCLE (CYC), and peaks around the early night. Relative to their mRNA peak, accumulation of PER and TIM proteins is delayed by \~6 hr. In the mid-to-late night, PER and TIM are predominantly nuclear, and once in the nucleus, they repress CLK-CYC activity to decrease *per* and *tim* expression. Degradation of TIM and then of PER in the morning resets the transcription cycle and restarts the loop. In order to maintain rhythmicity and set the proper pace of the circadian clock, both PER and TIM need to be dynamically regulated on multiple levels. For instance, a stable circadian molecular oscillator requires temporal delays to separate the phases of gene transcription and repression and thereby prevent these from reaching equilibrium ([@bib76]).

The overall levels and stability of TIM constitute a critical circadian modality. Although PER is the more important factor for transcriptional regulation, levels and activity of PER depend upon TIM ([@bib51]; [@bib20]). TIM levels are acutely modulated by light, which promotes the degradation of TIM, and thereby PER, during the day and allows the rise in circadian transcription ([@bib60]; [@bib69]). Subsequently, TIM accumulation is necessary to stabilize PER and promote its nuclear accumulation ([@bib34]). Thus, in the presence of light:dark cycles, light delays the accumulation of TIM-PER and so contributes to the lag in repression. These temporal relationships are largely preserved in constant darkness, and are also entrained by temperature cycles regardless of light cues, although the mechanisms under these conditions are not known.

While regulated protein stability and translation have been directly explored as mechanisms that could contribute to maintenance of the feedback loop ([@bib18]; [@bib11] ;[@bib38]; [@bib75]), and regulation of protein stability is indeed critical ([@bib76]), little investigation has focused on a potential role of alternative splicing. To date, the best-studied role for alternative splicing in Drosophila rhythms is in the temperature-dependence of the behavioral siesta ([@bib40]; [@bib41]; [@bib16]). Splicing is driven by spliceosomes, dynamic RNA-protein complexes composed of five core small nuclear ribonucleoprotein particles (U1, U2, U4, U5, U6 snRNP) and \>150 additional proteins specific for each snRNP complex ([@bib64]). In this study, we report a circadian role for Pre-mRNA Processing factor 4 (PRP4), a conserved component of the spliceosomal U4/U6.U5 triple small nuclear ribonucleoprotein (tri-snRNP) complex. We identified PRP4 in a screen for novel regulators of the free-running circadian period, and established that PRP4 is necessary in *tim+* clock cells to maintain 24 hr period and robust rhythms of the circadian clock. In addition to *prp4,* downregulation of multiple tri-snRNP components affected circadian period length and rhythmicity, which led us to implicate this entire spliceosomal complex in circadian regulation. Using unbiased RNA-Sequencing, we characterized the splicing events regulated by PRP4 and identified a novel intron retention event in *tim.* We show that alternative splicing of this intron in *tim* represents an important mechanism to time the daily accumulation of TIM, in constant darkness following entrainment to light:dark cycles and also in temperature cycles. Together, these findings identify a mechanism contributing to the maintenance of clock function.

Results {#s2}
=======

Pre-mRNA splicing factor four is a new regulator of the circadian clock {#s2-1}
-----------------------------------------------------------------------

In a screen for kinases that affect circadian period length of Drosophila rest:activity rhythms in constant dark:dark (DD) conditions, we identified Pre-mRNA Processing factor 4 (PRP4), a splicing factor that also has kinase activity ([@bib36]; [@bib56]). RNA interference (RNAi)-mediated knockdown of *prp4* in *tim+* clock neurons with the *Tim-UAS-Gal4* (*TUG*) Gal4 driver resulted in consistently long free-running circadian periods ([Figure 1A--B](#fig1){ref-type="fig"}). Two independent RNAi lines (GD and KK) were used to confirm these findings.

![Pre-mRNA splicing factor four is a new regulator of the circadian clock.\
(**A**) Representative activity records of free-running fly behavior upon downregulation of *prp4* in *tim+* neurons. *Dicer2* (*Dcr2*) was co-expressed with the RNAi transgenes to increase the knockdown efficiency. Genotypes are indicated on top of each panel. The gray and black bars indicate the subjective day and night, respectively. (**B**) The lengthening of free-running circadian period is significant for two independent *prp4* RNAi lines (GD and KK). \*\*\*\*p ≤ 0.0001 relative to heterozygous controls by one-way ANOVA and Tukey's post hoc test, n = 8--24. (**C**) Downregulation of *prp4* in *tim+* cells affects morning and evening anticipation in 12 hr:12 hr light:dark (LD) conditions. The activity profile of control (*TUG; Dcr2/+)* flies is in black, while the activity profile of experimental (*TUG*; *Dcr2 \>prp4^RNAi^*(*GD*)) flies is in red. The white and black bars indicate light and dark conditions, respectively. \*p ≤ 0.05, \*\*\*p ≤ 0.001,\*\*\*\*p ≤ 0.0001 to control (*TUG; Dcr2/+*) for each ZT range by two-way ANOVA and Sidak's post hoc test. Data represent mean ±SEM (n = 31--32). (**D**) Activity records demonstrate 7 days of representative free-running rhythms of *prp4* knockdown flies. *Dicer2 (Dcr2)* was co-expressed with the RNAi transgenes to increase the knockdown efficiency. Genotypes are indicated on top of each panel. The gray and black bars indicate the subjective day and night, respectively. (**E**) Knockdown of *prp4* in LNv pacemaker cells causes complex behavioral periods (p \< 0.0001 by χ^2^ analysis, n = 19--38). (**F, G**) Knockdown of *prp4* in LNvs lengthens circadian period and decreases rhythm strength. n.s., not significant at the 0.05 level, \*\*p ≤ 0.01, \*\*\*\*p ≤ 0.0001 to control (*pdfG4; Dcr2/+*) by one-way ANOVA and Holm-Sidak's post hoc test. Only rhythmic flies (FFT \> 0.01) were analyzed (n = 9--22). In panels (**B**), (**F**) and (**G**), the boxes extend from the 25th to 75th percentiles, the line within the box is plotted at the median and whiskers extend from the lowest to highest value.](elife-39821-fig1){#fig1}

The length of the free-running circadian period is an important parameter that also affects the daily distribution of fly activity in light:dark (LD) cycles. Thus, we determined the effect of *prp4* knockdown on fly diurnal activity in LD conditions ([Figure 1C](#fig1){ref-type="fig"}). Control (*TUG; Dcr2/+*) flies displayed characteristic bimodal activity in LD, with activity peaks that precede the onset of light (ZT0) and the onset of dark (ZT12). Compared to controls, the flies with circadian-cell-specific *prp4* knockdown (*TUG*; *Dcr2 \>prp4^RNAi^*(*GD*)) exhibited a delayed evening activity peak as well as a slightly delayed morning peak. These findings are consistent with the longer endogenous period that we report for *prp4* knockdown flies ([Figure 1A--B](#fig1){ref-type="fig"}).

As the small lateral ventral neurons (s-LNvs) are the most relevant clock cells for driving rest:activity rhythms under constant dark conditions, we asked if effects of PRP4 were mediated in these cells ([@bib30]). To test this hypothesis, we downregulated *prp4* in both s-LNvs and large lateral ventral neurons (l-LNvs) with *a Gal4* transgene driven by a peptide expressed specifically in these cells, Pigment Dispersing Factor (PDF). Knockdown of *prp4* with *pdf-Gal4* driving the weaker RNAi line (GD) led to a modest yet significant lengthening of free-running circadian period ([Figure 1F](#fig1){ref-type="fig"}). Interestingly, the knockdown of *prp4* with a stronger RNAi (KK) led to complex rhythms ([Figure 1E](#fig1){ref-type="fig"}). These complex rhythms were generally characterized by changes in the behavioral pattern, often manifest as phase shifts during day 4 or 5 of constant darkness (see \~6 hr shift in the record shown), in the midst of an otherwise rhythmic record ([Figure 1D](#fig1){ref-type="fig"}). Such a complex rhythm phenotype could reflect uncoupling of period into two components of *pdf*+ and *pdf-* cell oscillators ([@bib70]). Overall, these findings suggest that PRP4 action in LNvs contributes to maintaining clock function.

PRP4 is required for robust TIM and PER cycling {#s2-2}
-----------------------------------------------

Since our data indicated that PRP4 is necessary in LNvs for proper circadian rhythmicity ([Figure 1](#fig1){ref-type="fig"}), we next examined the circadian cycling of PER and TIM in s-LNvs at regular intervals around the clock ([Figure 2A--C](#fig2){ref-type="fig"}). Cycling of both PER and TIM was affected in s-LNvs upon *prp4* knockdown with the clock-specific *TUG* driver ([Figure 2A--C](#fig2){ref-type="fig"}). Total TIM levels, as quantified by corrected total cell fluorescence (CTCF) image analysis, were decreased during the night ([Figure 2B--C](#fig2){ref-type="fig"}). PER levels were also lower in the late night (ZT20), and especially so in the early morning (ZT2), in *prp4* knockdown flies ([Figure 2A,C](#fig2){ref-type="fig"}). Additionally, nuclear accumulation of PER was delayed beyond \~ZT20, the time point at which PER was already partially localized to the nucleus in control flies ([Figure 2A](#fig2){ref-type="fig"}). To further characterize the effect on nuclear expression, we profiled relative nuclear PER expression upon *prp4* knockdown with each of the two RNAi lines (GD and KK) in s-LNvs around the time of nuclear accumulation of PER (ZT18-ZT22). We found that the nuclear accumulation of PER was slower in flies with decreased *prp4* (both GD and KK RNAi lines) than in controls (*TUG*; *Dcr2/+*) at these time points ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Overall, our immunohistochemistry data point to a distinct molecular clock phenotype upon *prp4* downregulation. Because TIM is necessary for nuclear accumulation of PER ([@bib63]; [@bib55]; [@bib34]), reduced TIM accumulation could account for the delay and overall reduced nuclear expression of PER in s-LNvs ([Figure 2](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), which together could account for the longer free-running period.

![PRP4 is required for robust TIM and PER cycling.\
(**A, B**) Cycling of PER and TIM is disrupted in s-LNvs of *prp4* knockdown flies. Adult brains were dissected at time points indicated and immunostained with PER or TIM (green), PDF (magenta) and LaminC (blue) antibodies. *Dicer2 (Dcr2)* was co-expressed with the *prp4* RNAi transgene to increase its knockdown efficiency. Genotypes are indicated on the sides of each panel. The displayed images are representative of 2--3 independent experiments. (**C**) Corrected Total Cell Fluorescence (CTCF) was used to quantitatively assess the change in levels of PER and TIM in s-LNvs. The signal from both the nucleus and the cytoplasm was used to calculate CTCF. 10--21 cells from 5 to 8 brains were analyzed for ZT2, ZT14 and ZT20 and 8--10 cells from 3 to 5 brains for ZT8. Images were taken with identical confocal settings. \*p ≤ 0.05, \*\*p ≤ 0.01, \*\*\*p ≤ 0.001 to control (*TUG;Dcr2/+*) for each ZT time point as determined by two-way ANOVA and Sidak's post hoc test. Error bars = ± SEM. (**D**) PER phosphorylation is decreased and cycling of TIM is blunted in fly heads with pan-neuronal knockdown of *prp4. Dicer2* (*Dcr2*) was co-expressed with the *prp4* RNAi transgene to increase its knockdown efficiency. Adult fly heads were collected at indicated zeitgeber (ZT) time points in a 12 hr:12 hr light:dark cycle. Representative western blots probed for PER (right) or TIM (left) are shown. HSP70 was used as a loading control. (**E**) Total PER and TIM levels were quantified from western blots in (**D**). JTK cycle analysis identified significant cycling (p^JTK^ ≤ 0.01) for control (*elavGal4*; *Dcr2/+*) and not significant (n.s at the 0.05 level) cycling for samples with pan-neuronal *prp4* knockdown. Data represent mean ±SEM (n = 2--3 independent experiments).](elife-39821-fig2){#fig2}

As biochemical analysis of PER and TIM oscillations requires large amounts of tissue, we conducted pan-neuronal knockdown of *prp4* with the *elavGal4* driver. The pan-neuronal manipulation targeted *prp4* more broadly, allowing us to verify the efficiency of the knockdown through RNA analysis of whole heads. We consistently observed \~50% reduction in *prp4* RNA in head lysates of flies where it was knocked down pan-neuronally ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). This broad manipulation also allowed us to test the effects of *prp4* reduction on PER and TIM levels using western blotting of whole head lysates. The results obtained with this relatively crude method agreed well with our immunohistochemistry profiling of s-LNvs. First, we observed a strong effect of *prp4* downregulation on total TIM levels, particularly during the initial TIM accumulation phase (ZT10-18) ([Figure 2D--E](#fig2){ref-type="fig"}). Quantification of our western blot data across multiple experiments suggested that *prp4* knockdown also blunted the circadian cycling of TIM protein ([Figure 2E](#fig2){ref-type="fig"}). While the total levels of PER were not changed upon *prp4* downregulation, its phosphorylation profile was dampened. In control (*elavGal4; Dcr2/+*) flies, as previously reported ([@bib22]), PER was increasingly phosphorylated in the late night and early morning up until its degradation. In flies with reduced *prp4* levels, PER migrated at a lower molecular weight on western blots (ZT18-ZT2). We speculate that the dampened phosphorylation profile of PER reflects, at least in part, the defect in nuclear accumulation of PER because a number of sites on PER get phosphorylated only when PER starts to accumulate in the nucleus (after ZT20) ([@bib13]). Alternatively, *prp4* depletion could have a TIM-independent effect on PER to regulate its phosphorylation profile.

Circadian rhythmicity is modulated by tri-snRNP levels {#s2-3}
------------------------------------------------------

As noted above, PRP4 is associated with kinase activity, but it is also a component of the spliceosome ([@bib36]; [@bib56]). To address if the circadian role of PRP4 was spliceosome-dependent, we assayed circadian behavior following knockdown of additional tri-snRNP components. Strikingly, clock-specific downregulation of *pre-mRNA processing factor 3* (*prp3)* and *pre-mRNA processing factor 31* (*prp31*), which are associated primarily with U4/U6 snRNP, as well as *pre-mRNA processing factor 8* (*prp8)* and *bad response to refrigeration 2* (*brr2*), which are associated with U5 snRNP, caused pronounced defects in free-running circadian behavior ([Table 1](#table1){ref-type="table"}). The phenotypes ranged from period lengthening to complete arrhythmicity, suggesting that the overall levels and/or stability of tri-snRNP regulate circadian rhythms.

10.7554/eLife.39821.006

###### Free-running locomotor behavior of flies expressing RNAi against tri-snRNP components

  ----------------------------------------------------------------------------------------------------
  Genotype                               N    rhythmicity^\*^\   Period\           Power\
                                              (%)                (hours ± SEM)     (FFT ± SEM)
  -------------------------------------- ---- ------------------ ----------------- -------------------
  *TUG*; *Dcr2/*+                        35   100%               23.80 (0.06)      0.11 (0.01)

  *pdfGal4*, *Dcr2/+*                    19   100%               24.06 (0.06)      0.10 (0.01)

  *elavGal4*; *Dcr2/+*                   30   97%                23.59 (0.33)      0.06 (0.03)

  *+/prp4^RNAi^*(*GD*)                   16   100%               23.62 (0.06)      0.09 (0.01)

  *+/prp4^RNAi^*(*KK*)                   16   100%               23.32 (0.05)      0.13 (0.01)

  *+/prp3^RNAi^*(*GD*)                   10   100%               23.73 (0.06)      0.10 (0.01)

  *+/prp3^RNAi^*(*KK*)                   15   100%               23.45 (0.06)      0.12 (0.01)

  *+/prp8^RNAi^*(*GD*)                   15   100%               23.64 (0.07)      0.11 (0.01)

  *+/prp31^RNAi^*(*KK*)                  13   100%               23.35 (0.06)      0.12 (0.04)

  *+/brr2^RNAi^*(*KK*)                   16   100%               23.47 (0.06)      0.11 (0.01)

  *TUG*; *Dcr2 \> prp4^RNAi^*(*GD*)      34   71%^†^             26.55 (0.29)^‡^   0.09 (0.01)

  *TUG*; *Dcr2 \> prp4^RNAi^*(*KK*)      40   45%^†^             29.47 (0.48)^‡^   0.09 (0.01)

  *TUG*; *Dcr2 \> prp3^RNAi^*(*GD*)      11   100%               27.45 (0.49)^‡^   0.08 (0.02)

  *TUG*; *Dcr2 \> prp3^RNAi^*(*KK*)      33   0%^†^              \-                \-

  *TUG*; *Dcr2 \> prp8^RNAi^*(*GD*)      30   23%^†^             28.00 (1.02)^‡^   0.02 (0.01)^‡^

  *TUG*;*Dcr2 \> prp31^RNAi^*(*KK*)      17   88%                25.33 (0.19)^‡^   0.06 (0.01)^¶^

  *TUG*;*Dcr2 \> brr2^RNAi^*(*KK*)       24   0%^†^              \-                \-

  *pdfGal4, Dcr2 \> prp4^RNAi^*(*GD*)    30   90%                25.85 (0.32)^‡^   0.06 (0.01)^\|\|^

  *pdfGal4, Dcr2 \> prp4^RNAi^*(*KK*)    38   97%                24.81 (0.32)^‡^   0.09 (0.02)

  *elavGal4; Dcr2 \> prp4^RNAi^*(*GD*)   27   52%^†^             24.54 (0.14)^§^   0.03 (0.02)^\#^
  ----------------------------------------------------------------------------------------------------

\* Flies with FFT value \>0.01 are considered to be rhythmic.

†p \< 0.001 compared to both of the heterozygous controls, by χ^2^ analysis.

‡p \< 0.001 compared to both of the heterozygous controls, by Student's t test.

§p \< 0.001 compared to RNAi control but not significant (p \> 0.05) compared to *elavGal4; Dcr2/+* control, by.

Student's t test.

¶p \< 0.01 compared to *TUG; Dcr2/+* control but not significant (p \> 0.05) compared to RNAi control, by Student's t test.

\|\|p \< 0.01 compared to *pdfGal4; Dcr2/+* control and p \< 0.05 compared to RNAi control, by Student's t test.

\#p \< 0.05 compared to RNAi control but not significant (p \> 0.05) compared to *elavGal4; Dcr2/+* control, by Student's t test.

Note: [Table 1](#table1){ref-type="table"} is related to [Figure 3](#fig3){ref-type="fig"}.

To determine if the molecular signatures of *prp4* knockdown and other tri-snRNP downregulation phenotypes were similar, we performed s-LNv-specific analysis of PER and TIM levels with a few randomly selected RNAi lines. We found that the s-LNvs of flies with downregulated *prp8* had lower TIM levels at night, and also showed decreased nuclear accumulation at ZT20 relative to control flies ([Figure 3A](#fig3){ref-type="fig"}). These data allow us to conclude that circadian oscillations of PER (data not shown) and TIM are sensitive to changes in the levels of multiple tri-snRNP components.

![PRP8 regulates TIM levels and the strength of rest:activity rhythms.\
(**A**) TIM levels are decreased in s-LNvs of *prp8* knockdown flies. Adult brains were dissected at ZT14 and ZT20 on the 4^th^ day in LD cycle and immunostained with TIM (green), PDF (magenta) and LaminC (blue) antibodies. Genotypes are indicated on the sides of each panel. Displayed images are representative of two independent experiments. (**C**) Trans-heterozygous *prp8/brr2* mutants have weaker circadian rhythms compared to their heterozygous controls, p\* ≤ 0.05, p\*\* ≤ 0.01, p\*\*\* ≤ 0.001 by one-way ANOVA, Tukey post hoc test. All FFT value were used in the analysis, including the arrhythmic ones (FFT \< 0.01). Error bars represent mean ±SEM (n = 17--36). [Figure 3](#fig3){ref-type="fig"} is related to [Table 1](#table1){ref-type="table"}.](elife-39821-fig3){#fig3}

We further examined tri-snRNP function in circadian regulation by utilizing some of the previously characterized mutants of *prp8* and *brr2* ([@bib15]; [@bib4]). Because tri-snRNP components are essential genes with no homozygous viable knockout mutants described to date, we tested circadian behavior in the viable transheterozygous *prp8/brr2* mutants. The heterozygous *prp8/+* and *brr2/+* mutants displayed normal circadian rhythms, readily explained by the haplosufficiency of these two genes ([Figure 3B](#fig3){ref-type="fig"}). Transheterozygous *prp8/brr2* mutant flies had normal circadian period (data not shown), but displayed decreased rhythm strength compared to the *prp8/+* and *brr2/+* heterozygous flies, confirming a circadian function of the tri-snRNP ([Figure 3B](#fig3){ref-type="fig"}).

PRP4 regulates *tim* splicing {#s2-4}
-----------------------------

Next, we attempted to identify the mechanism by which PRP4 regulates circadian rhythms, starting with the broad hypothesis that downregulation of *prp4* leads to the aberrant splicing of one or more core clock transcripts. Analysis of clock transcripts indicated an increase in *tim* levels in the late night in flies with reduced *prp4* ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), but in order to apply an unbiased approach, we performed RNA-Sequencing (RNA-Seq) analysis of fly heads in which *prp4* had been knocked down. As clock protein expression in the eye contributes a majority of the signal in head assays, we used an eye-specific *Glass Multiple Promoter* (*GMR-Gal4*) driver for *prp4* knockdown. Overall gene expression was dramatically influenced by *prp4* downregulation (433 down, 310 up at FDR \< 0.05) ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Pathway enrichment analysis using DAVID identified changes in folate biosynthesis as well as in other broad pathway categories such as protein export, protein processing in endoplasmic reticulum and drug metabolism ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Interestingly, components of folate metabolism have been previously implicated in circadian clock regulation in human cells ([@bib73]). Despite the fact that PRP4 is a component of the core spliceosome required for constitutive splicing, we did not detect dramatic effects on global splicing. Using the Comprehensive AS Hunting (CASH) method, which assays for splicing events, our analysis identified 45 genes exhibiting differential splicing upon *prp4* downregulation, with FDR ≤ 0.05 (Wu, W., et al., 2017) ([Supplementary file 3](#supp3){ref-type="supplementary-material"}).

An intron retention event in *tim* that was significantly upregulated upon *prp4* knockdown was of particular interest due to its potential clock function ([Figure 4A--B](#fig4){ref-type="fig"}). Our initial splicing analysis was performed with CASH, but we additionally ran the Cufflinks-2.2 pipeline to obtain psi (percent spliced in) information for differentially spliced isoforms ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Importantly, the same retention event in *tim*, at position chr2L:3499764--3500000 (hereafter we refer to this intron as *tim-tiny* for simplicity), was consistently identified as significantly upregulated with both analyses ([Figure 4A](#fig4){ref-type="fig"}). For comparison, differential alternative splicing in only four other genes (*trol*, *pex7*, *Npc1a*, *vsg*) was consistently identified with both of the algorithms ([Figure 4A](#fig4){ref-type="fig"}). Moreover, the RNA-Seq reads across the *tiny-tiny* junction normalized to its neighboring junction (2L:3500362--3500422), which is spliced out in all of the *tim* isoforms, were significantly increased in the *prp4* knockdown samples (*GMR \>prp4^RNAi^*) compared to the controls (*GMR/+*), further pointing to the retention of *tim-tiny*. To estimate how common *tim-tiny* retention was in control flies (*GMR/+*), we quantified the ratio of isoforms that contain *tim-tiny* (*tim*-RM and *tim*-RS) to those that do not contain this intron using our Cufflinks-2.2 output ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). This analysis indicated that the isoforms retaining *tim-tiny* were twice as abundant as other isoforms at ZT 8 (when all of the RNA-Seq samples were collected) ([Supplementary file 5](#supp5){ref-type="supplementary-material"}).

![PRP4 regulates *tim* splicing.\
(**A**) Only five genes were identified as differentially spliced upon *prp4* downregulation with both CASH and Cufflinks/differential psi (percent spliced in) pipelines. For each gene, the corresponding p-value and False Discovery Rate (FDR) or q-value as determined by Benjamini-Hochberg (BH) procedure are reported. (**B**) *tim* isoforms (image adapted from Ensembl Fruitfly release 92, genome assembly BDGP6) are displayed. The boxes indicate exons, with filled boxes (brown) representing protein-coding sequences. The region of interest is enlarged (blue box) and depicts a constitutively spliced intron (*'ctrl'*) and the intron that gets retained upon *prp4* knockdown ('*tim-tiny'*). The chromosomal coordinates of these introns are indicated at their respective exon-intron junctions. (**C**) *tim-tiny* retention was revealed by RNA-Seq analysis in samples with *prp4* downregulated (*GMR \> prp4* RNAi). The number of RNA-Seq reads across the *tim-tiny* intron normalized to the number of reads across the *ctrl* intron is higher in *prp4* knockdown flies (*GMR \> prp4^RNAi^)* compared to controls (*GMR/+*). Data represent five independent biological replicates. Error bars represent mean RNAiSEM. \*p ≤ 0.0001 as determined by CASH (refer to panel A). (**D**) An increase in intron retention in flies with pan-neuronal *prp4* knockdown was confirmed with qPCR analysis. *Dicer2 (Dcr2)* was co-expressed with the *prp4* RNAi transgene to increase its knockdown efficiency. Data represent four independent biological replicates, with technical triplicates performed during the qPCR step for each replicate. \*\*p ≤ 0.01 to control (*elavGal4; Dcr2/+*) as determined by Student's t test. Data represent mean ±SEM.](elife-39821-fig4){#fig4}

Motivated by the RNA-Seq data, we sought to verify the retention of the *tim-tiny* intron upon pan-neuronal *prp4* knockdown. For this purpose, we designed primers that would amplify only the transcript containing the retained intron or only the spliced transcript respectively ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The ratio of retained to spliced signal would then indicate the relative intron retention. Using this approach, increased *tim-tiny* retention was consistently detected upon pan-neuronal *prp4* knockdown ([Figure 4D](#fig4){ref-type="fig"}). Additionally, by performing a control set of experiments, the signal from the 'retained' primer set targeting *tim-tiny* was verified not to reflect genomic DNA contamination ([Figure 4---figure supplement 2A--B](#fig4s2){ref-type="fig"}). First, retained intron levels were normalized to total *tim* mRNA. As total *tim* mRNA was amplified with primers that do not span junctions, but rather bind within sequences of a different exon ('exon'), they are also expected to detect any contaminating DNA in addition to mRNA. As with the *tim-tiny* retained/spliced ratio, the retained/exon ratio indicated increased *tim-tiny* retention upon *prp4* knockdown, in particular at ZT12, a time point used for our initial RNA-Seq analysis ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). Additionally, we amplified RNA using primers that span an exon-exon junction at a different part of *tim* ('mRNA'), which hence should only detect mRNA, and found that the ratio of *tim* 'exon' to 'mRNA' was not different between the control (*elavGal4*; *Dcr2/+*) and the *prp4* knockdown flies (*elavGal4*; *Dcr2 \> prp4^RNAi^*(*GD*)), indicating that residual DNA contamination does not contribute to the increased detection of *tim-tiny* with *prp4* knockdown ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}).

Intron retention in *tim* decreases TIM levels and affects circadian behavior {#s2-5}
-----------------------------------------------------------------------------

To assay the influence of *prp4*-dependent *tim-tiny* intron retention on TIM levels, we generated *tim* cDNA constructs that lacked the intron ('*tim*-spliced'), included the intron ('*tim*-retained') or included the intron along with a silent T \> A mutation in the 5' donor splice site at 2L:3499999 ('*tim*-retained-ssM') ([Figure 5A](#fig5){ref-type="fig"}). All constructs were transfected into S2 cells and assayed for their ability to drive expression of TIM protein. Intron inclusion had a drastic effect on the total levels of TIM, ranging from highest in the condition when no intron was present to no detectable full size TIM in the condition when splicing was blocked with the mutation ([Figure 5B](#fig5){ref-type="fig"}). Expression of the construct with the 5' splice site mutation led to low level production of a shorter TIM isoform that we called TIM^tiny^. This isoform was entirely absent when *tim* cDNA lacking the *tim-tiny* intron was expressed but was produced upon expression of the cDNA construct that included *tim-tiny*. Therefore, TIM^tiny^ is a truncated TIM isoform generated from the *tim* mRNA carrying an unspliced *tim-tiny* intron. Total mRNA levels were not different between these three experimental conditions, pointing to the post-transcriptional regulation of TIM protein abundance (data not shown).

![Intron retention in *tim* decreases TIM levels and affects circadian behavior.\
(**A**) Schematic depiction of three *tim* cDNA constructs used to assess the effect of *tim-tiny* retention (red block) on TIM levels. (**B**) Retention of *tim-tiny* intron decreases full-length TIM and leads to production of a minor TIM^tiny^ isoform. S2 cells were transfected with constructs described in (**A**) and western blots of cell lysates were probed with TIM antibody. Western blots are representative of 3 independent experiments. In the panels on the left, total levels of TIM isoforms upon expression of splice-specific cDNA constructs were quantified. TIM levels were normalized to HSP70 and expressed relative to the TIM^full^ levels in cells overexpressing a fully spliced (*tim*-spliced) construct. \*p ≤ 0.05, \*\*p ≤ 0.01, \*\*\*p ≤ 0.001, \*\*\*\*p ≤ 0.0001 by one-way ANOVA and Holm-Sidak's post hoc test. Data represent mean ±SEM (n = 3). (**C**) Western blots of head lysates of flies overexpressing *tim* cDNA with a 5' splice site mutation in *tim-tiny* (*TUG; Dcr2 \> tim*-retained+ssM) reveal production of TIM^tiny^ (arrow) and decrease in TIM^full^ compared to flies overexpressing intronless *tim* cDNA (*TUG*; *Dcr2 \> tim*spliced) or *tim* cDNA that includes *tim-tiny ((TUG; Dcr2 \> *tim retained). All flies were collected at ZT10, when endogenous TIM levels are low in control flies (*TUG; Dcr2/+).* Western blots are representative of 4 independent experiments. (**D**) Flies overexpressing *tim* cDNA constructs with 5' splice site mutation (*TUG*; *Dcr2 \>tim-*retained*+*ssM) do not lengthen circadian period. n = 6--26; n.s., not significant at the 0.05 level; \*\*\*\*p ≤ 0.0001 to control (*TUG*; *Dcr2/+*) by one-way ANOVA and Tukey's post hoc test. (**E**) *TUG*-driven expression of *tim* cDNA, with both '*tim*-spliced' and '*tim*-retained' constructs, rescues circadian rhythms in *tim^0^* flies. n.s., not significant at the 0.05 level, \*\*p ≤ 0.01, \*\*\*\*p ≤ 0.0001 by pairwise Fischer's exact test (n = 28--41). (**F**) *TUG*-driven rescue of *tim^0^* circadian rhythms with *tim* cDNA lacking *tim-tiny* (*tim^0^*,*TUG \> tim* spliced) results in shorter periods than with *tim* cDNA that includes *tim-tiny* (*tim^0^*,*TUG \> tim* retained). \*\*\*p ≤ 0.001 by Student's t test, n = 10--22.](elife-39821-fig5){#fig5}

Next, we overexpressed *tim* cDNA transgenes ([Figure 5A](#fig5){ref-type="fig"}) in flies, using a circadian cell driver (*TUG*). Normally, overexpression of *tim* using the Gal4-UAS system reduces rhythmicity and increases free-running periods, likely due to prolonged expression of the excess protein coupled with little negative feedback to downregulate production ([@bib69]). Overexpression of '*tim*-spliced' and '*tim*-retained' cDNAs caused lengthening of free-running periods ([Figure 5D](#fig5){ref-type="fig"}). However, the circadian behavior of flies overexpressing the cDNA construct with the 5' splice site mutation in *tim-tiny (TUG*; *Dcr2 \> tim-*retained + ssM) was not different from that of the controls (*TUG*; *Dcr2/+*). This would fit with our observations from S2 cells, which suggested a loss of full-sized TIM (TIM^full^) expression when *tim-tiny* was primed for selective retention. Thus, we hypothesized that overexpression of the construct with the 5' splice site mutation did not produce TIM^full^ in flies. We assayed TIM levels in flies overexpressing different *tim* cDNA constructs through western blots of fly head lysates collected at ZT10 when the endogenous TIM levels are low in controls (*TUG; Dcr2/+*) ([Figure 5C](#fig5){ref-type="fig"}). As predicted, flies that overexpressed '*tim*-retained-ssM' cDNA did not have increased TIM^full^ relative to controls, although both '*tim*-spliced' and '*tim*-retained' transgenes expressed abundant amounts of protein. Interestingly, we detected a band, likely corresponding to TIM^tiny^, in *TUG; Dcr2 \> tim-*retained + ssM flies, which was absent in the *TUG; Dcr2/+* controls. These data further corroborate our S2 cell findings and suggest that selective *tim-tiny* retention acts to reduce overall TIM levels.

To further understand the effect of *tim-tiny* splicing on circadian behavior, we overexpressed '*tim*-spliced', '*tim*-retained' and '*tim*-retained-ssM' using the *TUG* driver in the *tim^0^* homozygous background. We hypothesized that differential splicing of *tim-tiny* is necessary for the maintenance of circadian rhythmicity and so the '*tim*-retained' construct would rescue the behavioral rhythm most efficiently because it allows for both the splicing and retention of the intron. Additionally, because *prp4* knockdown increases the retention of *tim-tiny* ([Figure 4](#fig4){ref-type="fig"}) and prolongs the rhythm ([Figure 1](#fig1){ref-type="fig"}), we speculated that the '*tim*-spliced' construct would rescue with a shorter period than the '*tim*-retained' construct. As expected, the expression of *tim* cDNA with a 5' splice site mutation in *tim-tiny* ('*tim-*retained + ssM') did not restore rhythms in *tim^0^* flies ([Figure 5E](#fig5){ref-type="fig"}). The other two cDNA constructs, '*tim*-retained' and '*tim*-spliced' rescued rhythms in 54% and 32% of *tim^0^* flies, respectively. Importantly, there was a significant difference in period length between the flies that were rhythmic ([Figure 5F](#fig5){ref-type="fig"}). As discussed above, the UAS-GAL4 system typically over-expresses proteins and so rescues *per/tim* mutants with longer periods ([@bib69]), which we observed for the '*tim*-retained' isoform (\~26 hr). Shorter periods were seen with the '*tim*-spliced' version ([Figure 5F](#fig5){ref-type="fig"}), supporting the idea that *tim-tiny* retention promotes clock delays.

*tim* splicing is regulated by the clock and by temperature {#s2-6}
-----------------------------------------------------------

We next asked if the splicing of *tim* is under circadian regulation. For this purpose, we generated relative intron retention profiles across regular intervals under both LD and DD conditions ([Figure 6A--B](#fig6){ref-type="fig"}). In LD conditions, intron retention of *tim-tiny* did not display a significant cycle (by JTK analysis) but nevertheless showed a peak at ZT8. In DD conditions, interestingly, we observed robust cycling of *tim-tiny* with a crest at CT8. It was previously reported that the last (\~850 bp) intron in *tim* (also known as *tim-cold*) is also sometimes retained ([@bib6]). To determine if the retention of *tim-cold* is rhythmic, as is the retention of *tim-tiny*, we profiled *tim-cold* intron retention across a 24 hr cycle under different conditions. We found that *tim-cold* retention cycled in both LD and DD with similar phases, such that peak intron retention was during the day in LD and the subjective day in DD. To further verify that the cycling we detected for *tim* splicing was under clock control, we assayed *tim-tiny* and *tim-cold* intron retention profiles in *per^01^* mutant flies. In *per^01^* flies under both LD and DD conditions, the cycling of both *tim-tiny* and *tim-cold* intron retention was abolished, indicating that the circadian clock drives circadian oscillations in *tim* splicing. We suggest that retention of the *tim-tiny* intron during the day serves to delay the accumulation of TIM protein, in particular when light is not available to degrade TIM.

![*tim* splicing is regulated by the clock and by temperature.\
Flies were entrained for at least 3 days in 12 hr:12 hr light:dark (LD) conditions and collected in LD (A) or on the first day of transfer to constant darkness (B) at indicated ZT or CT time points, respectively. Splicing of *tim-tiny* and *tim-cold* introns was quantified as a ratio of retained to spliced levels using qPCR analysis. Three independent qPCR experiments were performed in triplicate, normalized to *rp49* and analyzed using the ∆∆Ct method. p^JTK^ indicates cycling as assessed by JTK cycle analysis for wild-type *iso^31^* flies (black) and *per^01^* circadian mutants (red). *tim-tiny* intron retention is increased in LD at ZT8 (A) as calculated by two-way ANOVA and Sidak's post hoc test, p\*\* ≤ 0.01. Wild-type *iso^31^* flies were collected at indicated ZT time points after at least four full days of entrainment in 12 hr:12 hr 30C:25C temperature cycles in constant dark (C) or constant light (D) conditions. Splicing of *tim-tiny* and *tim-cold* introns was quantified as a ratio of retained to spliced levels using qPCR analysis. Three independent qPCR experiments were performed in triplicate, normalized to *rp49* and analyzed using the ∆∆Ct method. p^JTK^ indicates cycling as assayed by JTK cycle analysis. Error bars = SEM.](elife-39821-fig6){#fig6}

It was previously reported that *tim-cold* retention is regulated by temperature and peaks at colder temperatures ([@bib6]). To determine if the splicing of *tim-tiny* was similarly sensitive to temperature, we used a temperature entrainment paradigm (12 hr:12 hr 30°C:25°C) under constant photic conditions ([Figure 6C--D](#fig6){ref-type="fig"}). In constant dark, temperature cycles were able to drive *tim* expression as previously reported (Glaser, F.T., and Stanewsky, R., 2005). Additionally, the profile of *tim-cold* retention was cyclic with the highest retention levels during the colder (25°C) temperatures. Interestingly, *tim-tiny* retention was robustly rhythmic under these temperature conditions, yet, unlike *tim-cold*, intron retention was increased by higher temperatures and decreased by lower ones. Thus, higher temperatures, which are typically associated with daytime hours, may reduce TIM levels by regulating the splicing of *tim-tiny*, while light does so through TIM degradation ([@bib32]; [@bib43]; [@bib72]; [@bib44]). We observed the same relationship and even more robust cycling of *tim-tiny* under temperature cycles (12 hr:12 hr 30°C:25°C) in constant light conditions ([Figure 6D](#fig6){ref-type="fig"}). In these conditions, *tim-cold* did not cycle, further indicating different regulation of these two splicing events in *tim*.

Discussion {#s3}
==========

In this study, we identify a novel alternative splicing (AS) mechanism that affects the pace of endogenous circadian oscillations and implicates PRP4 and other tri-snRNP components in circadian clock regulation. Importantly, our findings contribute to the understanding of a longstanding question in the circadian field, specifically how negative feedback by clock proteins is delayed in order to permit distinct phases, and therefore oscillations, of transcriptional activation and repression. In Drosophila, PER translation does not appear to be delayed relative to its mRNA production in a daily cycle ([@bib11]), but the protein is initially destabilized through its phosphorylation by the DOUBLETIME (DBT) kinase ([@bib52]). TIM stabilizes PER by alleviating this effect of DBT, and so accumulation of TIM, which only occurs after dark as TIM is degraded by light, determines the rise of PER. How this mechanism persists when light is not a cycling cue, for instance in constant darkness or in temperature cycles in constant light, was not known. Alternative splicing of the *tim-tiny* intron may be critical under these conditions.

The circadian profile of *tim-tiny* intron retention (i.e. high during the daytime) is consistent with it delaying the accumulation of TIM protein. Indeed, this mechanism is particularly robust in DD ([Figure 6](#fig6){ref-type="fig"}) and also in temperature cycles in constant light conditions ([@bib25]; [@bib71]). The retention of *tim-tiny* peaks at high temperatures, which correlates with low TIM levels (Glaser, F.T., and Stanewsky, R., 2005; [@bib71]). We propose a model ([Figure 7](#fig7){ref-type="fig"}) whereby the splice choice at the *tim-tiny* locus modulates the rate of TIM accumulation, which in turn affects the total levels of nuclear PER and TIM. The intron retention of *tim-tiny*, therefore, likely contributes to a delay between initial *tim* expression and accumulation of TIM, ensuring stability and robustness of the circadian oscillator. At the same time, the response of this splicing event to temperature promotes flexibility of the clock.

![Alternative splicing of the *tim*-tiny intron promotes oscillations of TIM levels.\
The model depicts how retention of the *tim-tiny* intron, which is increased upon downregulation of *prp4,* regulates TIM cycling. Both the circadian clock (**A**) and temperature cycles (**B**) regulate retention of the *tim-tiny* intron. (**A**) Increased retention of *tim-tiny* during the subjective day (light gray) in dark:dark (DD) conditions serves to decrease TIM levels and delay the accumulation of TIM in the absence of light. (**B**) Higher temperatures, typically associated with daytime hours, increase *tim-tiny* retention. Temperature cycles can maintain clock function under constant light conditions (LL), which would otherwise disrupt the clock. Entrainment by temperature appears to be driven by a reduction of TIM protein at the higher temperature (Yoshii, T., et al., 2005). We propose that under temperature cycles, retention of *tim-tiny* sets the levels of TIM and contributes to maintenance of the molecular clock.](elife-39821-fig7){#fig7}

Traditionally, it has been accepted that AS is driven by a set of auxiliary splicing factors, such as serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs), that act on *cis*-regulatory splicing modules and recruit U1 and U2 snRNP machinery ([@bib42]; [@bib8]; [@bib27]). However, studies from a range of organisms increasingly point to the involvement of the core spliceosomal machinery not only in AS execution but also in splice junction selection ([@bib9]; [@bib10]; [@bib14]; [@bib47]; [@bib50]). Our RNA-seq findings further support the idea that the abundance/stability of at least some components of the core spliceosome has an effect on a select subset of AS events, while constitutive splicing seems to be unperturbed ([Supplementary file 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}). A functional network of spliceosomal proteins has been proposed on the basis of their knockdown phenotypes ([@bib46]). According to this model, PRP4 resides within the tri-snRNP regulatory module, which largely coincides with the previously reported physical interactions between the components of the tri-snRNP ([@bib17]; [@bib7]; [@bib56]). Our findings of similar circadian behavioral effects caused by loss of any of several tri-snRNP components strongly implicate the tri-snRNP complex in circadian regulation ([Table 1](#table1){ref-type="table"}). It remains to be established how the decreased abundance of tri-snRNP components triggers changes in alternative splicing. We hypothesize that tri-snRNP level/activity is limiting for a subset of AS reactions, likely the ones with weaker splice sites. This hypothesis is supported by two recent studies reporting that (1) *Prp4* in fission yeast is necessary to recognize and splice the introns with weak splice sites ([@bib21]) and (2) decreased availability of mammalian *Prpf8* leads to the selective retention of introns that harbor weak 5' splice sites (Wickramasinghe, V.O., et al., 2015).

We speculate that tri-snRNP components constitute a well-conserved regulatory module for circadian clocks. Conservation of the circadian role of tri-snRNP is suggested by several findings. First, the human homolog of PRP4 was identified as a hit in a genome-wide RNAi screen for regulators of the circadian clock ([@bib73]). Secondly, SM-like (LSM) proteins that are associated with U6 snRNP were recently shown to regulate circadian rhythmicity in both *Arabidopsis* and in mammalian cell culture ([@bib49]). Finally, some tri-snRNP components (Prpf8, Prpf31 and SART1) physically associate with mammalian PER2 complexes, further highlighting potential cross-talk between central clock components and the tri-snRNP ([@bib35]).

Although AS has been implicated in the regulation of circadian clocks, it has not been linked to clock function in the manner we report here. In *Neurospora crassa*, the ratio of alternatively spliced *frequency (frq)* isoforms determines the robustness of circadian rhythmicity and fine-tunes the period length ([@bib24]; [@bib39]). In *Arabidopsis thaliana*, AS regulates the circadian clock by multiple mechanisms, such as the production of new isoforms that competitively inhibit functional clock proteins ([@bib58]) and the modulation of clock RNA levels via the nonsense-mediated decay (NMD) pathway ([@bib33]; [@bib37]). In *Drosophila*, the alternative splicing regulator SR-related matrix protein of 160 kDa (SRm160) modulates PER levels locally in the pacemaker neurons to regulate circadian rhythms ([@bib3]). The key theme that emerges from these studies is that AS acts directly on core clock components to set their levels. Alternatively, splicing mechanisms could regulate diurnal rhythmicity of neuronal excitability, as proposed for splicing of BK channels in the suprachiasmatic nucleus ([@bib59]).

Our study identifies a novel splicing event in *tim* that can regulate TIM levels in both cell culture and in flies ([Figure 5](#fig5){ref-type="fig"}). How does the splicing affect TIM levels? It is unlikely that the retention of *tim-tiny* leads to NMD-mediated RNA decrease because the flies with *prp4* downregulated do not have reduced *tim* levels ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). On the contrary, overall *tim* RNA levels tend to be increased in those flies. Additionally, expression of *tim* cDNA constructs with constitutively retained *tim-tiny* ([Figure 5](#fig5){ref-type="fig"}) decreases TIM levels without altering *tim* mRNA levels (data not shown). Therefore, we suggest that it is either the *tim* mRNA translation step or the stability of the truncated TIM isoform, TIM^tiny^, produced by *tim-tiny* that is sub-optimal. The 267 amino acids at the C-terminus of TIM that are predicted to be lost in TIM^tiny^ include a putative cytoplasmic localization signal ([@bib54]) as well as a predicted threonine phosphorylation site ([@bib5]), both of which could significantly change stability and function of TIM. Notably, TIM^tiny^ is typically not detected in western blots of TIM expression in flies, so it appears that *tim-tiny* retention serves only to reduce the amount of *tim* RNA that can effectively produce protein.

While studying the effect of *tim-tiny* retention in isolation can give us a quick snapshot of its importance, overall splicing of *tim* is considerably more complex. In parallel to *tim-tiny*, in this study we examined the splicing profile of a previously reported *tim-cold* intron ([@bib6]). Cycles of *tim-tiny* and *tim-cold* intron retention are similar under light:dark and constant dark conditions ([Figure 6](#fig6){ref-type="fig"}), but temperature cycles have different effects on the splicing of these two introns. *tim-tiny* intron retention increases with hot temperature, whereas *tim-cold* intron retention increases at the onset of the cold cycle ([Figure 6](#fig6){ref-type="fig"}). Also, *tim-cold* retention does not cycle in temperature cycles in LL, suggesting that it does not contribute to rhythmicity under these conditions. *tim-tiny* intron is upstream of *tim-cold*, which means that *tim-tiny* retention should lead to TIM downregulation regardless of the splicing decision at the *tim-cold* locus. Following differential splicing at *tim-tiny* locus, *tim-cold* could get either retained or spliced, introducing an additional regulatory layer. The interplay of AS at the level of these two introns can produce a range of TIM isoforms, the roles of which remain to be elucidated, particularly with respect to temperature entrainment.

In Drosophila, splicing of *D. melanogaster per* intron 8 (*dmip8*), the intron located in the 3' untranslated region (UTR) of *per*, is regulated by both light and temperature ([@bib16]; [@bib41]; [@bib40]). This splicing mechanism allows flies to delay their evening behavior during long photoperiods and/or high temperatures, and might play a role in seasonal adaptation. On a molecular level, *dmip8* retention delays *per* mRNA and PER protein accumulation. While *dmip8* retention was not identified in our initial RNA-Seq data ([Supplementary file 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}), our follow up qPCR splicing analysis suggested that PRP4 modestly regulates *per* splicing ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}). *dmip8* retention has a small effect on the free-running period length (\~25 hr period) ([@bib12]; [@bib40]), but it cannot fully account for the period lengthening phenotype we report for flies with downregulated *prp4* ([Figure 1A--B](#fig1){ref-type="fig"}; [Table 1](#table1){ref-type="table"}).

Studies in *Arabidopsis* suggest that the expression of a number of tri-snRNP components is regulated by the circadian clock ([@bib48]). In Drosophila, recent profiling of mRNA cycling in different neuronal clusters detected *prp4* mRNA oscillations in DN1 clock neurons and *brr2* cycling in LNvs ([@bib1]). While these RNA-Seq findings have not been verified through other approaches, they lead us to hypothesize that diurnal oscillations in tri-snRNP components drive circadian splicing of *tim* ([Figure 6](#fig6){ref-type="fig"}) and potentially other circadian output genes locally in specific clock neurons. This hypothesis is further strengthened by another recent report ([@bib65]) that suggests heterogeneous alternative splicing profiles for different circadian neuronal groups. In addition to changes in total levels of PRP4, circadian regulation of its kinase activity could contribute to differential splicing of *tim* over the course of the day. We establish a role for PRP4 in LNvs, the key pacemaker cluster necessary for the maintenance of circadian cycles under constant dark conditions ([Figure 1](#fig1){ref-type="fig"}). However, based on our findings that splicing of *tim* is regulated by temperature and persists in constant light ([Figure 6](#fig6){ref-type="fig"}), we speculate that PRP4 also functions in DN1s, clock cells implicated in temperature sensing and entrainment ([@bib68]; [@bib74]). In summary, while much of the focus in the circadian field has been on transcriptional or post-translational control, our findings indicate a critical role for alternative splicing, perhaps in a cell-type-specific manner.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource   Designation                 Source or reference           Identifiers                                                  Additional information
  ------------------------------------ --------------------------- ----------------------------- ------------------------------------------------------------ ------------------------
  Gene\                                *prp4*                      NA                            FLYB:FBgn0027587                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Gene\                                *timeless (tim)*            NA                            FLYB:FBgn0014396                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Gene\                                *period (per)*              NA                            FLYB:FBgn0003068                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Gene\                                *prp8*                      NA                            FLYB:FBgn0033688                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Gene\                                *brr2*                      NA                            FLYB:FBgn0263599                                             also known\
  (Drosophila\                                                                                                                                                as *l(3)72Ab*
  melanogaster)                                                                                                                                               

  Gene\                                *prp3*                      NA                            FLYB:FBgn0036915                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Gene\                                *prp31*                     NA                            FLYB:FBgn0036487                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Strain, strain\                      *iso^31^*                   from laboratory\              NA                                                           
  background\                                                      stocks                                                                                     
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic\                             *per^01^*                   Bloomington\                  FLYB:FBal0013649                                             
  reagent\                                                         Drosophila\                                                                                
  (Drosophila\                                                     Stock Center\                                                                              
  melanogaster)                                                    (BDSC)                                                                                     

  Genetic reagent\                     *tim^0^*                    BDSC                          FLYB:FBal0035778                                             
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *TUG*\                      BDSC                          FLYB:FBtp0011839                                             
  (Drosophila\                         (*Tim-UAS-Gal4*)                                                                                                       
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *pdfGal4;*\                 BDSC                          FLYB:FBtp0011844                                             
  (Drosophila\                         *pdfG4*                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *elavGal4;*\                BDSC                          BDSC:25750                                                   
  (Drosophila\                         *elavG4*                                                                                                               
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *GMRGal4;*\                 BDSC                          FLYB:FBti0002994                                             
  (Drosophila\                         *GMR*                                                                                                                  
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp4^RNAi^*(*GD*)          Vienna\                       VDRC:27808                                                   
  (Drosophila\                                                     Drosophila\                                                                                
  melanogaster)                                                    Resource\                                                                                  
                                                                   Center\                                                                                    
                                                                   (VDRC)                                                                                     

  Genetic reagent\                     *prp4^RNAi^*(*KK*)          VDRC                          VDRC:107042                                                  
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp8^RNAi^*(*GD*)          VDRC                          VDRC:18565                                                   
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp3^RNAi^*(*GD*)          VDRC                          VDRC:25547                                                   
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp3^RNAi^*(*KK*)          VDRC                          VDRC:103628                                                  
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp31^RNAi^*(*KK*)         VDRC                          VDRC:103721                                                  
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *brr2^RNAi^*(*KK*)\         VDRC                          VDRC:110666                                                  
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *prp8^2e1^*                 BDSC                          FLYB:\                                                       
  (Drosophila\                                                                                   FBal0190235;\                                                
  melanogaster)                                                                                  BDSC:25905                                                   

  Genetic reagent\                     *prp8^2e2^*                 BDSC                          FLYB:FBal0190015;\                                           
  (Drosophila\                                                                                   BDSC:25912                                                   
  melanogaster)                                                                                                                                               

  Genetic\                             *brr2^e03171^*              BDSC                          FLYB:FBti0041681;\                                           
  reagent\                                                                                       BDSC:18127                                                   
  (Drosophila\                                                                                                                                                
  melanogaster)                                                                                                                                               

  Genetic reagent\                     *UAS-Dicer2;*\              BDSC                          FLYB:FBtp0036672                                             
  (Drosophila\                         *Dcr2*                                                                                                                 
  melanogaster)                                                                                                                                               

  Genetic reagent\                     UAS*-tim-*spliced;\         this paper                    NA                                                           generated by\
  (Drosophila\                         *tim-*spliced                                                                                                          the site-specific\
  melanogaster)                                                                                                                                               PhiC31 Integration\
                                                                                                                                                              System\
                                                                                                                                                              (Rainbow\
                                                                                                                                                              Transgenics) using\
                                                                                                                                                              the attP on\
                                                                                                                                                              the 3^rd^ chromosome;\
                                                                                                                                                              pUAST-*tim*-spliced\
                                                                                                                                                              plasmid was\
                                                                                                                                                              used for\
                                                                                                                                                              injection

  Genetic reagent\                     UAS*-tim-*retained;\        this paper                    NA                                                           generated by the\
  (Drosophila\                         *tim-*retained                                                                                                         site-specific\
  melanogaster)                                                                                                                                               PhiC31 Integration\
                                                                                                                                                              System\
                                                                                                                                                              (Rainbow\
                                                                                                                                                              Transgenics)\
                                                                                                                                                              using the attP\
                                                                                                                                                              on the 3^rd^\
                                                                                                                                                              chromosome;\
                                                                                                                                                              pUAST-*tim*-\
                                                                                                                                                              retained\
                                                                                                                                                              plasmid was\
                                                                                                                                                              used for\
                                                                                                                                                              injection

  Genetic reagent\                     UAS*-tim-*retained+ssM;\    this paper                    NA                                                           generated by the\
  (Drosophila\                         *tim-*retained+ ssM                                                                                                    site-specific\
  melanogaster)                                                                                                                                               PhiC31 Integration\
                                                                                                                                                              System\
                                                                                                                                                              (Rainbow\
                                                                                                                                                              Transgenics) using\
                                                                                                                                                              the attP on\
                                                                                                                                                              the 3^rd^ chromosome;\
                                                                                                                                                              pUAST-*tim*-\
                                                                                                                                                              retained+ssM\
                                                                                                                                                              plasmid was\
                                                                                                                                                              used for\
                                                                                                                                                              injection

  Cell line\                           S2                          ATCC\                         FLYB:FBtc0000181;\                                           
  (Drosophila\                                                     (Manassas,\                   RRID:[CVCL:Z992](https://scicrunch.org/resolver/CVCL:Z992)   
  melanogaster)                                                    VA)                                                                                        

  Antibody                             guinea pig anti-\           [@bib23]                      NA                                                           1:1000
                                       PER (UP1140)                                                                                                           

  Antibody                             rat anti-\                  [@bib34]                      NA                                                           1:1000
                                       TIM (UPR42)                                                                                                            

  Antibody                             rabbit\                     [@bib23]                      NA                                                           1:500
                                       anti-PDF (HH74)                                                                                                        

  Antibody                             mouse\                      Developmental\                LC28.26                                                      1:500
                                       anti-LaminC                 Studies\                                                                                   
                                                                   Hybridoma Bank\                                                                            
                                                                   (DSHB)                                                                                     

  Antibody                             mouse\                      Sigma                         Cat\# H5147                                                  1:5000
                                       anti-HSP70                                                                                                             

  Recombinant\                         pIZ/V5-His\                 ThermoFischer                 Cat\# V800001                                                backbone
  DNA reagent                          plasmid                                                                                                                

  Recombinant\                         pBluescript-*tim*           lab collection                NA                                                           *tim* sequence\
  DNA reagent                                                                                                                                                 contained\
                                                                                                                                                              *tim-tiny;*\
                                                                                                                                                              used for\
                                                                                                                                                              subcloning

  Recombinant\                         *tim*-spliced;\             this paper                    NA                                                           *tim* cDNA was\
  DNA reagent                          pIZ-*tim*-spliced                                                                                                      subcloned into\
                                                                                                                                                              pIZ-V5 plasmids

  Recombinant\                         *tim*-retained;\            this paper                    NA                                                           *tim-tiny* intron\
  DNA reagent                          pIZ-*tim*-retained                                                                                                     was subcloned\
                                                                                                                                                              into pIZ-*tim*-\
                                                                                                                                                              spliced\
                                                                                                                                                              vector from\
                                                                                                                                                              pBluescript-*tim*\
                                                                                                                                                              plasmid

  Recombinant\                         *tim*-retained+ ssM;\       this paper                    NA                                                           generated by\
  DNA reagent                          pIZ-*tim*-retained+ssM                                                                                                 mutagenesis of\
                                                                                                                                                              the 5' splice donor\
                                                                                                                                                              site of *tim-tiny*\
                                                                                                                                                              intron from\
                                                                                                                                                              pIZ-*tim*-retained\
                                                                                                                                                              plasmid

  Recombinant\                         *tim*-spliced;\             this paper                    NA                                                           *tim* cDNA was\
  DNA reagent                          pUAST-*tim*-spliced                                                                                                    subcloned\
                                                                                                                                                              from pIZ-*tim*-\
                                                                                                                                                              spliced into pUAST\
                                                                                                                                                              -attB vector

  Recombinant\                         *tim*-retained;\            this paper                    NA                                                           *tim* cDNA was\
  DNA reagent                          pUAST-*tim*-retained                                                                                                   subcloned from\
                                                                                                                                                              pIZ-*tim*-retained\
                                                                                                                                                              into pUAST-attB\
                                                                                                                                                              vector

  Recombinant\                         *tim*-retained + ssM;\      this paper                    NA                                                           *tim* cDNA was\
  DNA reagent                          pUAST-*tim*-retained+ssM                                                                                               subcloned from\
                                                                                                                                                              pIZ-*tim*-\
                                                                                                                                                              retained+ssM\
                                                                                                                                                              into pUAST-attB\
                                                                                                                                                              vector

  Sequence-\                           *tim* PP11542\              ATGGACTGGTTACTAGCAACTCC                                                                    
  based reagent                        ('mRNA') \_F                                                                                                           

  Sequence-\                           *tim* PP11542\              GGTCCTCATAGGTGAGCTTGT                                                                      
  based reagent                        ('mRNA') \_R                                                                                                           

  Sequence-\                           *per*\_F                    CGTCAATCC\                                                                                 
  based reagent                                                    ATGGTCCCG                                                                                  

  Sequence-\                           *per*\_R                    CCTGAAAGACGCGATGGTG                                                                        
  based reagent                                                                                                                                               

  Sequence-\                           *clk*\_F                    GGATGCCAATGCCTACGAGT                                                                       
  based reagent                                                                                                                                               

  Sequence-\                           *clk*\_R                    ACCTACGAAAGTAGCCCACG                                                                       
  based reagent                                                                                                                                               

  Sequence-\                           *prp4*\_F                   CACAAGCAGCATCTTTGTATGG                                                                     
  based reagent                                                                                                                                               

  Sequence-\                           *prp4*\_R                   TGTGGAGTCCCACATTCTTG                                                                       
  based reagent                                                                                                                                               

  Sequence-\                           *tim-tiny*\_retained_F      AAACGTGAGTTAAAGTCAACC                                                                      
  based reagent                                                                                                                                               

  Sequence-\                           *tim-tiny*\_retained_R      GAGAGGCACACAGCATATC                                                                        
  based reagent                                                                                                                                               

  Sequence-\                           *tim-tiny*\_spliced_F       CCGCTGGACAAACTCAACCTC                                                                      
  based reagent                                                                                                                                               

  Sequence-\                           *tim-tiny*\_spliced_R       TCGGTATCGCCGAGATCCACG                                                                      
  based reagent                                                                                                                                               

  Sequence-\                           *tim-cold*\_retained_F      GGCTCATGATCATTGCAGCAGC                                                                     
  based reagent                                                                                                                                               

  Sequence-\                           *tim-cold*\_retained_R      ATAGTGGGGCACCCGGATCTC                                                                      
  based reagent                                                                                                                                               

  Sequence-\                           *tim-cold*\_spliced_F       TTAAACAGCGACAATGTCTCTTTGG                                                                  
  based reagent                                                                                                                                               

  Sequence-\                           *tim-cold*\_spliced_R       GAATTGGATCCTCAGTGATAGTGGG                                                                  
  based reagent                                                                                                                                               

  Sequence-\                           *tim*\_non_spanning\        GAAGAACAACGATATTGTGGGAAAG                                                                  
  based reagent                        (\'exon\')\_F                                                                                                          

  Sequence-\                           *tim*\_non_spanning\        AGTGGGAGTTGTCAGCAAAG                                                                       
  based reagent                        (\'exon\')\_R                                                                                                          

  Sequence-\                           *per*\_retained_F           GAGGACCAGACACAGCACGG                                                                       
  based reagent                                                                                                                                               

  Sequence-\                           *per*\_retained_R           CGGAGGCAATTGCTCACTCGT                                                                      
  based reagent                                                                                                                                               

  Sequence-\                           *per*\_spliced_F            GAGGACCAGACACAGCACGG                                                                       
  based reagent                                                                                                                                               

  Sequence-\                           *per*\_spliced_R            TCGCGTTGATTCGAAGAATCGTT                                                                    
  based reagent                                                                                                                                               

  Sequence-\                           *rp49*\_F                   GACGCTTCAAGGGACAGTATCTG                                                                    
  based reagent                                                                                                                                               

  Sequence-\                           *rp49*\_R                   AAACGCGGTTCTGCATGAG                                                                        
  based reagent                                                                                                                                               

  Sequence-\                           *tim_tiny*SSdonorT \> A_F   CTGGACAAACGAGAGTTAAAGTCAACC                                                                
  based reagent                                                                                                                                               

  Sequence-\                           *tim_tiny*SSdonorT \> A_R   CGGTCCCAGCTTTTTGGC                                                                         
  based reagent                                                                                                                                               

  Commercial\                          RNeasy\                     Qiagen                        Cat\# 74134                                                  
  assay or kit                         Plus Mini Kit                                                                                                          

  Commercial\                          Superscript II\             ThermoFischer                 Cat\# 18064014                                               
  assay or kit                         Reverse Transcriptase                                                                                                  

  Commercial\                          TRIzol Reagent              ThermoFischer                 Cat\# 15596026                                               
  assay or kit                                                                                                                                                

  Commercial\                          Q5 Site-Directed\           NEB                           Cat\# E0554S                                                 
  assay or kit                         Mutagenesis Kit                                                                                                        

  Commercial\                          Effectene Transfection\     Qiagen                        Cat\# 301425                                                 
  assay or kit                         Reagent                                                                                                                

  Software,\                           Graphpad\                   Graphpad\                     <https://www.graphpad.com/>                                  
  algorithm                            Prism v7                    Software                                                                                   

  Software,\                           JTK_CYCLE v3                [@bib31]                      NA                                                           
  algorithm                                                                                                                                                   

  Software,\                           ImageJ                      NIH                           <https://imagej.nih.gov/ij/>                                 
  algorithm                                                                                                                                                   

  Software,\                           ClockLab\                   Actimetrics\                  <https://actimetrics.com/products/clocklab>                  
  algorithm                            Software                    (Wilmette, IL)                                                                             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly husbandry and stocks {#s4-1}
------------------------

Fly stocks and crosses were maintained at room temperature or at 18°C on standard cornmeal molasses medium. Stocks for RNAi overexpression were obtained from VRDC. *brr2^e03171^*, *prp8^2e1^*, *prp8^2e2^* mutants were obtained from the Bloomington stock center. *iso^31^*, *per^01^* and *Gal4* stocks were from the Sehgal lab stock collection. Transgenic lines for *tim* cDNA overexpression were generated by the site-specific PhiC31 Integration System (Rainbow Transgenics) using the attP on the 3^rd^ chromosome. The DNA for fly embryo injections contained *tim* cDNA constructs ([Figure 5A](#fig5){ref-type="fig"}) subcloned into pUASTattB vectors.

Circadian behavior analysis {#s4-2}
---------------------------

For free-running circadian analysis, male flies were entrained to 12 hr:12 hr light:dark (LD) cycles at 25°C for at least three complete cycles. Flies were loaded into TriKinetics Drosophila Activity Monitor (DAM) system (Trikinetics, Waltham, MA), released into constant darkness and recorded for at least 7 days. Circadian parameters (period and rhythm strength) were determined using Clocklab Software (Actimetrics, Wilmette, IL). Period length was determined with χ2 periodogram analysis. Rhythm strength was determined using Fast Fourier Transform (FFT) values. A fly was considered rhythmic if the FFT value was greater than 0.01.

For analysis of circadian behavior in LD, flies were stably entrained in LD at 25°C for 3 days and their behavior was recorded as described above for the next three subsequent days. The analysis of activity counts was performed using Insomniac3 Software (RP Metrix).

Immunohistochemistry and confocal microscopy {#s4-3}
--------------------------------------------

Fly brains were dissected in 4% paraformaldehyde (PFA) in 1x phosphate-buffered saline (PBS), fixed in PFA for 20 min at room temperature (RT) and then additionally trimmed of the air sacs and other contaminating tissues in 1xPBST. Dissected brains from each time point were stored in 1xPBST at 4°C until all of the time points were collected (never for more than 8 hr). Once all dissections and fixations were completed, brains were washed in 1xPBST for 20 min at RT, blocked with 5% Donkey Serum (DS) in 1xPBST for 20 min at RT, and incubated with the primary antibodies diluted in 5% DS overnight with gentle shaking at 4°C. The primary antibodies included rat anti-TIM (UPR42, 1:1000), guinea pig anti-PER (UP1140, 1:1000), rabbit anti-PDF (HH74, 1:500) and mouse anti-LaminC (LC28.26 from Developmental Studies Hybridoma Bank, 1:500). After a 30 min wash in 1xPBST at RT, brains were incubated with secondary antibodies diluted in 5% DS at RT. Secondary antibodies were used at 1:500 dilution and included FITC donkey-anti-guinea pig (Rockland), Alexa555 donkey-anti-rabbit (Jackson Immuno), Alexa647 donkey-anti-mouse (Jackson Immuno). Samples were washed for 30 min in 1xPBST at RT, and mounted in VectaShield. Slides were imaged with a Leica SP5 confocal microscope using a 40x oil-immersion objective and a 0.5 μM step size. The signal was adjusted to be not saturated as determined by QLUT parameters. After this original adjustment, all the settings were kept constant for a given experimental set. ImageJ software was used for analysis.

Western blot analysis {#s4-4}
---------------------

Western blot assays with fly heads were performed as previously described ([@bib23]). Briefly, 7--10 fly heads per genotype/condition were lysed in 1x Passive Lysis Buffer (Promega), supplemented with protease and phosphatase inhibitors. For S2 cell extracts, 48 hr after transfection, cells were collected and lysed in the same buffer as described for fly heads. The following primary antibodies were used: anti-PER (UP1140, 1:1000), anti-TIM (UPR42, 1:1000) and anti-HSP70 (Sigma, 1:5000).

Plasmids and S2 cell culture {#s4-5}
----------------------------

For cell culture expression, *tim* cDNA was subcloned into pIZ-V5 plasmids. Using standard restriction enzyme cloning technique, the *tim-tiny* intron was subcloned into pIZ-V5 vectors carrying intronless *tim* cDNA from the pBluescript-*tim* plasmid. Mutagenesis of the 5' splice donor of *tim-tiny* intron site was performed with primers catalogued in the Key resources table using Q5 Site-Directed Mutagenesis Kit (NEB).

S2 cells were cultured in a standard Schneider medium (Invitrogen) supplemented with 10% FBS (Sigma). Transfection was done using an Effectene kit (Qiagen) according to the manufacturer's protocol.

Quantitative RT-PCR {#s4-6}
-------------------

Flies were collected on dry ice at indicated time points and stored at −80°C until all of the time points were collected (within 24 hr). Fly heads were then collected on dry ice and homogenized with TRIzol (ThermoFischer) on ice using standard protocols. Following the phase separation, the aqueous phase was transferred into a new tube, mixed with an equal volume of 70% ethanol and loaded directly onto the RNeasy mini kit columns (Qiagen). The rest of the RNA isolation was done according to the manufacturer's protocol. On-column DNase digestion (Qiagen) for 15 min at RT was always included. cDNA was generated with Superscript II (Invitrogen), according to the manufacturer's protocol. Quantitative RT-PCR reaction was performed in a ViiA7 Real-Time PCR system (Applied Biosystems) using SYBR Green Master Mix (Applied Biosystems) with gene specific primers. Relative gene expression was calculated using the ΔΔCt method with *rp49* as normalization control.

RNA-Sequencing and data analysis {#s4-7}
--------------------------------

RNA extraction was performed as described in the 'Quantitative RT-PCR' section above. Tapestation (Agilent) was used to ensure that all of RNA samples were of high-quality (RIN \>8). five samples per each genotype were selected and prepared with Lexogen's SENSE mRNA-Seq library Prep Kit. Illumina Next-Generation Sequencing (NextSeq 500) with 300pb paired-end high output run (at \~50M reads per sample) was performed by the Genomics Facility at the Wistar Institute, Philadelphia, PA.

The RNA-seq reads were aligned to the Drosophila genome (dm6.BDGP6.v88) using STAR version 2.5.3a ([@bib19]). Normalization and quantification were performed with the PORT version 0.8.2a-beta pipeline ([@bib26]) which first removes reads that map to ribosomal RNA sequences or mitochondrial DNA and then uses a read re-sampling strategy for normalization to minimize unwanted variance such as differences in sequencing depth among the samples. PORT normalization was performed before quantification, at the aligned read level. After normalization, the quantification of features (genes, exons, introns, junctions) was done with respect to the Ensemblv88 annotation. The differential expression analysis was performed using the R Bioconductor package limma-voom ([@bib53]). General pathway enrichment analyses were performed using DAVID (<https://david.ncifcrf.gov/>). The top 743 differentially expressed genes upon *prp4* downregulation, corresponding to FDR ≤ 0.05, were used for pathway enrichment analysis. Differential splicing analysis for *prp4* knockdown samples (with respect to the control) was performed using CASH ([@bib67]). Full transcript quantification was done using Cufflinks-2.2, and differential psi (percent spliced in) analysis was performed for various gene isoforms to identify alternate splicing events ([@bib62]; [@bib61]).

Quantification and statistical analysis {#s4-8}
---------------------------------------

The statistical parameters are included in the legends of each figure. JTK_CYCLEv3.1 was run in R for circadian statistical analyses. GraphPad Prism was used for all other statistical tests.

Data deposition {#s4-9}
---------------

The RNA-Seq data generated in this work are freely available at the Gene Expression Omnibus (GEO) standard repository (accession \# GSE115163).
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In the interests of transparency, eLife includes the editorial decision letter, peer reviews, and accompanying author responses.

\[**Editorial note:** This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor\'s assessment is that all the issues have been addressed.\]

Thank you for submitting your article \"Spliceosome Factors Target *timeless (tim*) to Maintain Clock Function and Circadian Behavior in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: John Ewer (Reviewer \#1). The other reviewers remain anonymous.

The Reviewing Editor has highlighted the concerns that require revision and/or responses, and we have included the separate reviews below for your consideration. If you have any questions, please do not hesitate to contact us.

Summary:

As described in the authors\' Abstract: \"Transcription-translation feedback loops that comprise eukaryotic circadian clocks rely upon temporal delays that separate the phase of active transcription of clock genes, such as *Drosophila period (per)* and *timeless (tim),* from negative feedback by the two proteins. However, mechanisms underlying such delays are unclear. Through an RNA interference screen, \[the authors\] found that pre-mRNA processing 4 (PRP4) kinase, a component of the U4/U5.U6 triple small nuclear ribonucleoprotein(tri-snRNP) spliceosome, and other tri-snRNP components regulate cycling of the molecular clock as well as rest:activity rhythms. Unbiased RNA-Sequencing uncovered an alternatively spliced intron in *tim* whose increased retention upon *prp4* downregulation leads to decreased TIM levels. \[They\] demonstrate that the splicing of *tim* is rhythmic with a phase that parallels delayed accumulation of the protein in a 24-hour cycle. \[The authors\] propose that alternative splicing \[(in addition to regulation of protein translation)\] constitutes an important clock mechanism for delaying the daily accumulation of clock proteins, and thereby negative feedback by them.\"

Major concerns:

Please respond to all of the major comments from all three reviewers since they raise specific items that should be addressed. As pointed out by Reviewer 3, \"the major unresolved conceptual issue is how the differential splicing of this intron is produced throughout the day by the clock. The authors speculate that daily changes in the level of splicing factors (and there is some evidence for this in earlier tissue-specific RNA profiling analyses) might produce the altered intron inclusion. Since *prp4* is a kinase, there might also be circadian regulation of its kinase activity. This possibility could be mentioned in the discussion." The minor comments from Reviewer 3 should also be addressed.

As suggested by Reviewer 2, the title does not say much about the mechanism. The authors should consider the title suggested by Reviewer 2: \"Spliceosome Factors Target timeless mRNA to control protein accumulation in the *Drosophila* circadian oscillator.\"

The original reviewers' comments are appended below.

Separate reviews (please respond to each point):

*Reviewer \#1:*

This is an interesting manuscript that shows that the regulation of the spliceosome itself contributes to the mechanisms that set the periodicity of the circadian clock. It nicely extends recent findings by Wang et al., 2018 (10.7554/*eLife*.35618) by identifying an intron in the timeless gene whose retention, due to actions mediated by components of the U4/U5.U6 spliceosome, (likely) delays the accumulation of TIM protein, thereby affecting the exact periodicity of the clock.

I am no expert in RNAseq analyses, so can\'t weigh in on this issue. The rest of the work is solid and well documented, and the conclusions are warranted. Some of the effects are quite modest, but then again, the effects on the clock, while biologically very significant, are \"numerically\" also modest (in few areas of biology is a change from \~24 to \~26 very impressive).

My only comments refer to the text.

1\) Abstract \"However, mechanisms underlying such delays are unclear.\" I would say that the mechanisms are not \"unclear\" but that \"our understanding of the mechanisms involved is incomplete\" since there is clear evidence (mentioned in the manuscript, for instance, in the Introduction final paragraph) that phosphorylation, protein stability, and dimerization of PER and TIM, all contribute to the functioning and period-setting of the clock.

2\) Results section: \"Overall, these findings strongly suggest that the free-running circadian component of the *prp4*-knockdown phenotype maps to LNvs.\" Rather than \"maps\" I would say, \"the function of *prp4* in LNvs contributes to setting the periodicity of the clock\". This because the knocking down *prp4* in all clock neurons (Figures 1A, B) is not quite the same as knocking it down only in LNvs (Figures 1D-G).

3\) Discussion section: \"Importantly, our findings address a longstanding question in the circadian field, specifically how negative feedback by clock proteins is delayed in order to permit distinct phases, and therefore oscillations, of transcriptional activation and repression.\" Rather than \"address\" I would say, \"contribute to our understanding of\".

4\) In the Introduction and Discussion I think it is appropriate to cite the work of Beckwith et al., 2017 (10.1534/genetics.117.300139), which shows that alternative-splicing regulator, SR-related matrix protein of 160 kDa (SRm160), affects gene expression in pacemaker neurons.

5\) In the Discussion I think it is worth mentioning another situation where a specific alternative splicing event has an impact on clock function, namely the BK potassium channel, where inclusion of a specific exon changes the electrophysiological properties of the channel, most likely contributing to the circadian changes in firing rate of SCN (work from Andrea Meredith\'s lab).

Minor Comments:

Difficult to resist suggesting that rather than \"*tim-tiny*\", this intron be called \"Tiny tim\"....

Additional data files and statistical comments:

The most relevant data (RNA-Seq data) have been made available (Gene Expression Omnibus standard repository, accession \# GSE115163).

*Reviewer \#2:*

This is a very interesting study by the Sehgal lab that reveals a new mechanism regulating TIM protein accumulation by producing a truncated unstable TIM protein during daytime. This is a new post-transcriptional mechanism that sheds light on the most obscure part of the negative feedback loop: how is PER/TIM protein accumulation delayed in comparison to the mRNA oscillation. The study represents a lot of smart work, the experiments are clearly presented and it is relatively easy to follow the paper. The data look really convincing although I will have a couple of suggestions.

-- Results section and Figure 1: complex behavioral rhythms are obtained when *prp4* is downregulated in PDF cells whereas long period rhythms are obtained with all-clock neurons downregulation (Figure 1). To me, it suggests that *prp4* downregulation has also effects in pdf- oscillators, which is no surprise. I would not simply conclude that the *prp4*-knockdown phenotype maps to LNvs.

-- Subsection "PRP4 is required for robust TIM and PER cycling" and Figure 2: the PER phosphorylation phenotype is strong (Figure 2D). The authors propose that it is a consequence of a defect in PER nuclear transfer, due to TIM decrease. I think that the possibility of a direct effect of *prp4* on PER should be tested by comparing PER phosphorylation in *prp4*+ and *prp4* RNAi flies with a *tim^0^* genetic background. I acknowledge that it might not be easy to see since TIM affects PER phosphorylation, but I believe that it is an important point to clarify.

Would it be possible to analyze the effects of a similar decrease of TIM (50% decrease at ZT18-20 based on Figure 2E) but as a consequence of another molecular defect, on PER phosphorylation?

-- Subsection "PRP4 regulates *tim* splicing": It is unclear to me how the 45 genes exhibiting differential splicing (Supplementary file 4, which I could not find) compare to the 5 genes that are described in Figure 3A. Is it the different analysis method? Please clarify.

-- Subsection "PRP4 regulates tim splicing" third paragraph and Figure 3 (+ Figure 4---figure supplement 2): I understand that *tim-tiny* mRNA is increased by two-fold in *prp4* RNAi flies (Figure 3D). However, I suppose that the relative quantity of tim-tiny mRNA in comparison to total *tim* mRNA is a key parameter when it comes to explaining the effects of splicing regulation on total TIM protein levels. Please clearly indicate in the text what fraction of total *tim* mRNA *tim-tiny* represents in wild type flies.

It seems to me the effects of the different *tim* cDNAs on TIM protein levels (S2 cells and transgenic flies in Figure 4) are difficult to extrapolate to wild type and *prp4* RNAi flies if this ratio is not known. Does Figure 4---figure supplement 2B indicate that the spliced and retained forms are present in similar amounts?

Figure 5 and 6: I understand that the *tim-tiny/tim* ratio is indeed close to 1 in average. If I understand this well, that would say that half of *tim* transcripts do not produce a functional TIM protein. I believe that this point should be emphasized in the paper even before telling about the cycling of this ratio.

Minor Comments:

-- The title does not tell much about the mechanism and I would suggest to make it more specific. For example, something in this line: Spliceosome Factors Target timeless mRNA to control protein accumulation in the *Drosophila* circadian oscillator

-- Zheng and Sehgal, 2012 (Introduction section) does not seem to be in the list of references

-- Figure 2 legend: E is quantification from D rather than A?

*Reviewer \#3:*

This manuscript describes a well done investigation of broad interest to the circadian rhythm field because it demonstrates a novel clock-controlled splicing event in the RNA of a circadian clock gene (timeless, or *tim*) and makes a compelling argument that this splicing event introduces a delay in the accumulation of full length TIM protein. Such a delay has been postulated to be essential for the generation of oscillating expression for circadian proteins like PERIOD (PER) and TIM, but the delay has been proposed to arise from post-translational regulation of protein phosphorylation and stability (The post-translational effects are not disputed here; splicing is an additional regulatory step). Early circadian regulation of *per* and *tim* splicing has been shown to be needed for photoperiodic and temperature input pathways to the clock, but not for the underlying oscillation itself. Therefore, this manuscript will be of general interest. It is a very complete effort, with support for the role of RNA splicing coming from alterations to free-running period, rhythmicity and PER/TIM expression from knock-down of several splicing factors, identification in RNA-seq studies of a *tim* intron that is preferentially maintained with knock-down of one of these splicing factors (*prp4*), demonstration of altered effects on the oscillator with expression of mRNAs specific for the different alternative splice products, and demonstration of enhanced splicing for inclusion of the intron during the middle of the day or with higher temperatures, under conditions when it could delay the accumulation of TIM protein. The enhanced splicing event is particularly prominent in DD and may comprise a specific mechanism to confer phase delays of TIM accumulation in DD.

The major unresolved conceptual issue is how the differential splicing of this intron is produced throughout the day by the clock. The authors speculate that daily changes in the level of splicing factors (and there is some evidence for this in earlier tissue-specific RNA profiling analyses) might produce the altered intron inclusion. Since *prp4* is a kinase, there might also be circadian regulation of its kinase activity. This possibility could be mentioned in the Discussion.

Minor Comments:

1\) Two lines on Table 1 are both labeled TUG\>Dcr2;*prp4* RNAi (GD), but one of these (probably the second one) should perhaps be labeled KK instead of GD. Do these lines target different regions of the *prp4* mRNA to show the effects are target specific? And why does the \"stronger\" KK line have less effect on period length and rhythmicity than the GD line (Figure 1F and G)?

2\) Define the differences between the boxes and error bars on Figure 1.

3\) While the text states that the morning peak of activity is triggered by lights in Figure 1C, there still seems to be some anticipation -- just less than in the control.

4\) The complex rhythm in Figure 1D seems to include an \~6hr phase shift at the end of the record. Please comment on this in the text. The figure legend indicates that these rhythms are double-plotted but they appear to be single-plotted.

5\) Why are the intervals for the collection of samples for TIM analysis in figure 2E 2hr long while they are precise times for PER analysis?

6\) There does not seem to be a Supplementary file 3 nor a Supplementary file 4.

7\) The model presented in Figure 6 argues that the delayed accumulation of TIM during the day due to inclusion of the extra intron (which truncates the reading frame of the protein) introduces a phase delay into the clock. But overexpression of cDNA with this intron missing produces longer periods, which apriori is inconsistent with the model (it should speed the clock, not slow it). Presumably the overexpression is producing some additional effects like prolonged repression of the E box, outside the confines of the model. Some discussion of this point is needed.

Additional data files and statistical comments:

Supplementary files 3 and 4 are missing and are important. They need to be provided. The statistical analysis is fine.

10.7554/eLife.39821.024

Author response

Reviewer \#1:

> \[...\] My only comments refer to the text.
>
> 1\) Abstract \"However, mechanisms underlying such delays are unclear.\" I would say that the mechanisms are not \"unclear\" but that \"our understanding of the mechanisms involved is incomplete\" since there is clear evidence (mentioned in the manuscript, for instance, in the Introduction final paragraph) that phosphorylation, protein stability, and dimerization of PER and TIM, all contribute to the functioning and period-setting of the clock.
>
> 2\) Results section: \"Overall, these findings strongly suggest that the free-running circadian component of the prp4-knockdown phenotype maps to LNvs.\" Rather than \"maps\" I would say, \"the function of prp4 in LNvs contributes to setting the periodicity of the clock\". This because the knocking down prp4 in all clock neurons (Figures 1A, B) is not quite the same as knocking it down only in LNvs (Figures 1D-G).
>
> 3\) Discussion section: \"Importantly, our findings address a longstanding question in the circadian field, specifically how negative feedback by clock proteins is delayed in order to permit distinct phases, and therefore oscillations, of transcriptional activation and repression.\" Rather than \"address\" I would say, \"contribute to our understanding of\".

For points 1-3, the text of the manuscript was revised as suggested.

> 4\) In the Introduction and Discussion I think it is appropriate to cite the work of Beckwith et al., 2017 (10.1534/genetics.117.300139), which shows that alternative-splicing regulator, SR-related matrix protein of 160 kDa (SRm160), affects gene expression in pacemaker neurons.

The following sentence was included in the Discussion: "In *Drosophila*, the alternative splicing regulator SR-related matrix protein of 160 kDa (SRm160) modulates PER levels locally in the pacemaker neurons to regulate circadian rhythmicity (Beckwith et al., 2017)".

> 5\) In the Discussion I think it is worth mentioning another situation where a specific alternative splicing event has an impact on clock function, namely the BK potassium channel, where inclusion of a specific exon changes the electrophysiological properties of the channel, most likely contributing to the circadian changes in firing rate of SCN (work from Andrea Meredith\'s lab).

The following sentence was included in the Discussion: "Alternatively, splicing mechanisms could regulate diurnal rhythmicity of neuronal excitability, as proposed for splicing of BK channels in the suprachiasmatic nucleus (Shelley et al., 2013)."

> Minor Comments:
>
> Difficult to resist suggesting that rather than \"tim-tiny\", this intron be called \"Tiny tim\"....
>
> Additional data files and statistical comments:
>
> The most relevant data (RNA-Seq data) have been made available (Gene Expression Omnibus standard repository, accession \# GSE115163).

Reviewer \#2:

> \[...\] The data look really convincing although I will have a couple of suggestions.
>
> -- Results section and Figure 1: complex behavioral rhythms are obtained when prp4 is downregulated in PDF cells whereas long period rhythms are obtained with all-clock neurons downregulation (Figure 1). To me, it suggests that prp4 downregulation has also effects in pdf- oscillators, which is no surprise. I would not simply conclude that the prp4-knockdown phenotype maps to LNvs.

We agree that the circadian effects of *prp4* are unlikely to be mediated exclusively by sLNvs. However, because the *pdf-*selective downregulation of *prp4* can drive altered circadian behavior, we conclude that *pdf+* clock cells contribute to setting the periodicity of the clock. As per Reviewer 1's suggestion, we modified the text to "Overall, these findings suggest that the function of PRP4 in LNvs contributes to setting the periodicity of the clock" instead of *\"*Overall, these findings strongly suggest that the free-running circadian component of the *prp4*-knockdown phenotype maps to LNvs."

Additionally, we modified the sentence to: "We identified PRP4 in a screen for novel regulators of the free-running circadian period, and established that PRP4 is necessary in clock *tim+* cells, to maintain 24-hour period and robust rhythmicity of the circadian clock."

> -- Subsection "PRP4 is required for robust TIM and PER cycling" and Figure 2: the PER phosphorylation phenotype is strong (Figure 2D). The authors propose that it is a consequence of a defect in PER nuclear transfer, due to TIM decrease. I think that the possibility of a direct effect of prp4 on PER should be tested by comparing PER phosphorylation in prp4+ and prp4 RNAi flies with a tim^0^ genetic background. I acknowledge that it might not be easy to see since TIM affects PER phosphorylation, but I believe that it is an important point to clarify.
>
> Would it be possible to analyze the effects of a similar decrease of TIM (50% decrease at ZT18-20 based on Figure 2E) but as a consequence of another molecular defect, on PER phosphorylation?

This is a very good point. To better acknowledge that *prp4*-dependent PER phosphorylation phenotype could be independent of *prp4* effects on TIM, we added the following sentence to the Results section: "Alternatively, *prp4* depletion could have a TIM-independent effect on PER to regulate its phosphorylation profile."

It would be very difficult to examine effects of *prp4* on PER phosphorylation in a *tim^0^* background because loss of TIM alone dramatically reduces levels of PER and affects PER phosphorylation, which would likely obscure effects of *prp4* (Price et al., 1995). We considered the possibility of examining a 50% decrease in TIM by using *tim^0^*/+ flies, but as these flies do not have a behavioral phenotype, they would not be relevant in terms of explaining the *prp4* phenotype. We believe that reduction of TIM in flies with *prp4* downregulation is greater in sLNvs than across the rest of the brain. Nevertheless, it is true that some aspects of the *prp4* phenotype might be independent of TIM, so it is best to acknowledge this as we propose to do above.

> -- Subsection "PRP4 regulates tim splicing": It is unclear to me how the 45 genes exhibiting differential splicing (Supplementary file 4, which I could not find) compare to the 5 genes that are described in Figure 3A. Is it the different analysis method? Please clarify.

To clarify the methods used to analyze the RNA-Seq data, we changed the sentence to "Using the Comprehensive AS Hunting (CASH) method, which assays for splicing events, our analysis identified 45 genes exhibiting differential splicing upon *prp4* downregulation with FDR ≤ 0.05 (Wu et al., 2017) (Supplementary File 3)." To further narrow down relevant targets, we utilized additional algorithms and identified overlapping splicing events. We state this point as "Our initial splicing analysis was performed with CASH, but we additionally ran the Cufflinks-2.2 pipeline to obtain psi (percent spliced in) information for differentially spliced isoforms (Supplementary File 4)." The 5 genes described in Figure 4A are the overlapping targets identified by both of the splicing algorithms. We believe the legend of Figure 4 clearly makes this point: "(A) Only 5 genes were identified as differentially spliced upon *prp4* downregulation with both CASH (Wu et al., 2017) and Cufflinks/differential psi (percent spliced in) pipelines (Trapnell et al., 2010; Trapnell et al., 2013)."

> -- Subsection "PRP4 regulates tim splicing" third paragraph and Figure 3 (+ Figure 4---figure supplement 2): I understand that tim-tiny mRNA is increased by two-fold in prp4 RNAi flies (Figure 3D). However, I suppose that the relative quantity of tim-tiny mRNA in comparison to total tim mRNA is a key parameter when it comes to explaining the effects of splicing regulation on total TIM protein levels. Please clearly indicate in the text what fraction of total tim mRNA tim-tiny represents in wild type flies.
>
> It seems to me the effects of the different tim cDNAs on TIM protein levels (S2 cells and transgenic flies in Figure 4) are difficult to extrapolate to wild type and prp4 RNAi flies if this ratio is not known. Does Figure 4---figure supplement 2B indicate that the spliced and retained forms are present in similar amounts?
>
> Figure 5 and 6: I understand that the tim-tiny/tim ratio is indeed close to 1 in average. If I understand this well, that would say that half of tim transcripts do not produce a functional TIM protein. I believe that this point should be emphasized in the paper even before telling about the cycling of this ratio.

We agree that the ratio of isoforms that contain *tim-tiny (tim*-RM and *tim*-RS) to those that do not contain this intron is an important parameter to highlight in our study. We revisited our Cufflinks-2.2 analysis of the RNA-Seq data to better calculate this ratio (provided in the new Supplementary File 5). This analysis indicated that the isoforms that retain *tim-tiny* are twofold more abundant than isoforms that do not contain it (at ZT 8 when all of the RNA-Seq samples were collected). This finding would imply that at ZT8 the majority of *tim* isoforms do not produce full-sized TIM or produce unproductive protein that is rapidly degraded (Figure 5). As our data indicate, the ratio of spliced and unspliced forms changes over time (Figure 6A-B). The new information about the ratio is included in the following sentence: "To estimate how common *tim-tiny* retention was in control flies (*GMR/+)*, we quantified the ratio of isoforms that contain *tim-tiny (tim*-RM and *tim*-RS) to those that do not contain this intron using our Cufflinks-2.2 output (Supplementary File 4). This analysis indicated that the isoforms retaining *tim-tiny* were twice as abundant as other isoforms (at ZT 8 when all of the RNA-Seq samples were collected) (Supplementary File 5)."

> Minor Comments:
>
> -- The title does not tell much about the mechanism and I would suggest to make it more specific. For example, something in this line: Spliceosome Factors Target timeless mRNA to control protein accumulation in the Drosophila circadian oscillator.

To incorporate the effect on circadian behavior, we have changed the title to: "Spliceosome Factors Target timeless mRNA to control protein accumulation and circadian behavior in *Drosophila*"

> -- Zheng and Sehgal, 2012 (Introduction section) does not seem to be in the list of references

The reference was added.

> -- Figure 2 legend: E is quantification from D rather than A?

The figure legend was corrected.

Reviewer \#3:

> \[...\] The major unresolved conceptual issue is how the differential splicing of this intron is produced throughout the day by the clock. The authors speculate that daily changes in the level of splicing factors (and there is some evidence for this in earlier tissue-specific RNA profiling analyses) might produce the altered intron inclusion. Since prp4 is a kinase, there might also be circadian regulation of its kinase activity. This possibility could be mentioned in the Discussion.

The following sentence was added to the Discussion: "In addition to changes in total levels of PRP4, circadian regulation of its kinase activity could contribute to differential splicing of *tim* over the course of the day."

> Minor Comments:
>
> 1\) Two lines on Table 1 are both labeled TUG\>Dcr2;prp4 RNAi (GD), but one of these (probably the second one) should perhaps be labeled KK instead of GD. Do these lines target different regions of the prp4 mRNA to show the effects are target specific? And why does the \"stronger\" KK line have less effect on period length and rhythmicity than the GD line (Figure 1F and G)?

The second line was corrected to "*TUG\>Dcr2;prp4 RNAi (KK)"* in Table 1.

With respect to the strength of the KK line, we believe the reviewer is referring to the non-significant effect of KK on period with the *pdf* driver. However, please note that a very small percentage of these flies have a single rhythm that could be analyzed for period, as opposed to flies with GD driven by *pdf* (Figure 1E-F). We consider the KK line 'stronger' than GD because KK has a longer average period and less rhythmicity than GD when driven with the TUG driver (Figure 1B, Table 1).

The GD line (VDRC:27808) and KK line (VDRC:107042) target distinct, but overlapping regions of *prp4*.

> 2\) Define the differences between the boxes and error bars on Figure 1.

The boxes extend from the 25th to 75th percentiles. The line in the middle of the box is plotted at the median. Whiskers extend from the lowest to highest value. Since the same description would be relevant for Figure 5D, we updated the legends of both Figure 1 and Figure 5.

> 3\) While the text states that the morning peak of activity is triggered by lights in Figure 1C, there still seems to be some anticipation -- just less than in the control.

The text was adjusted to "Compared to controls, the flies with circadian-cell-specific *prp4* knockdown (*TUG; Dcr2\>prp4^RNAi^ (GD)*) exhibited a delayed evening activity peak as well as a slightly delayed morning peak"

> 4\) The complex rhythm in Figure 1D seems to include an \~6hr phase shift at the end of the record. Please comment on this in the text. The figure legend indicates that these rhythms are double-plotted but they appear to be single-plotted.

The reviewer is correct in that there appears to be a phase shift (delay or advance) in many records. We have modified the sentence to read: "These complex rhythms were generally characterized by changes in the behavioral pattern, often manifest as phase shifts during day 4 or 5 of constant darkness (see \~6-h shift in the record shown), in the midst of an otherwise rhythmic record (Figure 1D)."

We apologize for the inaccuracy and have deleted the word 'double-plotted'.

> 5\) Why are the intervals for the collection of samples for TIM analysis in Figure 2E 2hr long while they are precise times for PER analysis?

There was no strategic reason for this. For the TIM analysis, we pooled data from multiple experiments in which samples were collected at similar, but not identical, times so we indicated the collection times as intervals.

> 6\) There does not seem to be a Supplementary file 3 nor a Supplementary file 4.

These files will be uploaded with the final paper submission.

> 7\) The model presented in Figure 6 argues that the delayed accumulation of TIM during the day due to inclusion of the extra intron (which truncates the reading frame of the protein) introduces a phase delay into the clock. But overexpression of cDNA with this intron missing produces longer periods, which apriori is inconsistent with the model (it should speed the clock, not slow it). Presumably the overexpression is producing some additional effects like prolonged repression of the E box, outside the confines of the model. Some discussion of this point is needed.

Overexpression of *tim* cDNA from the UAS promoter typically results in longer periods as it does not allow for feedback and so leads to massive accumulation of TIM (Yang and Sehgal, 2001). Please note that earlier studies showing period-shortening with PER over-expression used constructs that included a *per* promoter that could be repressed by feedback (discussed in Yang and Sehgal, 2001). It is true that we do not see a period difference with '*tim-*retained' and '*tim-*spliced' overexpression constructs (Figure 5D), which may be because these constructs have small effects in a wild type background. However, the reviewer is absolutely correct in that the "intron missing" form should produce shorter periods than the '*tim-*retained' form, and we now show the data for expression of these constructs in a *tim^0^* background (included as Figure 5E-F; also shown below). Note that both forms rescue with a longer period, as expected of UAS constructs, but rescue with the spliced form ('*tim-*spliced') yields a shorter period, albeit in a smaller percentage of flies. The latter point of lower rhythmicity also supports our idea that delays are required for a robust oscillator.

We added the following sentences to the legend of Figure 5: "(E) *TUG*-driven expression of *tim* cDNA, with both '*tim*-spliced' and '*tim*-retained' constructs, rescues *tim^0^* circadian rhythmicity. n.s., not significant at the 0.05 level, \*\*p ≤ 0.01, \*\*\*\*p ≤ 0.0001 by pairwise Fischer's exact test (n=28-41). (F) *TUG*-driven rescue of *tim^0^* circadian rhythms with *tim* cDNA that includes *tim-tiny (tim^0^,TUG\>tim*-retained) lengthened the period compared to the rescue with *tim* cDNA lacking *tim-tiny (tim^0^,TUG\>tim*-spliced). \*\*\*p ≤ 0.001 by Student's t test, n=10-22."

These findings were summarized in the Results section as "To further understand the effect of *tim-tiny* splicing on circadian behavior, we overexpressed '*tim*-spliced', '*tim*-retained' and '*tim*-retained-ssM' using the *TUG* driver in the *tim^0^*homozygous background. We hypothesized that splicing of *tim-tiny* is necessary for the maintenance of circadian rhythmicity and so the '*tim*-retained' construct would rescue the behavioral rhythmicity most efficiently because it allows for both the splicing and retention of the intron. Additionally, because *prp4* knockdown increases the retention of *tim-tiny* (Figure 4) and prolongs the rhythm (Figure 1), we speculated that the '*tim*-spliced' construct would rescue with a shorter period than the '*tim*-retained' construct. As expected, the expression of *tim* cDNA with a 5' splice site mutation in *tim-tiny* ('*tim-*retained+ssM') did not restore rhythms in *tim^0^* flies (Figure 5E). The other two cDNA constructs, '*tim*-retained' and '*tim*-spliced' rescued the rhythmicity in 54% and 32% of *tim^0^* flies, respectively. Importantly, there was a significant difference in period length between the flies that were rhythmic (Figure 5F). As discussed above, the UAS-GAL4 system typically over-expresses proteins and so rescues *per/tim* mutants with longer periods (Yang and Sehgal, 2001), which we observed for the '*tim*-retained' isoform (\~26 hours). Shorter periods were seen with the '*tim*-spliced' version (Figure 5F), supporting the idea that *tim-tiny* retention promotes clock delays."

We changed the title of Figure 5 to "Intron retention in *tim* decreases TIM levels and affects circadian behavior" to better convey the message of the new panels.

> Additional data files and statistical comments:
>
> Supplementary files 3 and 4 are missing and are important. They need to be provided. The statistical analysis is fine.

The files will be uploaded.
